POPULARITY
2 episodes with Blayney
3 episodes with Blayney
2 episodes with Blayney
2 episodes with Blayney
2 episodes with Blayney
3 episodes with Blayney
2 episodes with Blayney
2 episodes with Blayney
2 episodes with Blayney
Wenn der Ex-Partner unseres Partners in dessen Leben noch eine Rolle spielt, kann uns das verunsichern. Dieses Gefühl der rückwirkenden Eifersucht ist ziemlich verbreitet, sagt die Psychologin Tina Rosenberger. Forscherin Jessica Frampton sagt: Soziale Medien können das verstärken. (Wiederholung vom 06.11.2024)**********Ihr hört: Moderation: Przemek Żuk Gesprächspartnerin: Minou (Name auf Wunsch geändert), hat Erfahrungen mit retroaktiver Eifersucht auf Ex-Partner Gesprächspartnerin: Paulina (Name auf Wunsch geändert), hat Erfahrungen mit retroaktiver Eifersucht gemacht Gesprächspartnerin: Tina Rosenberger, Diplom-Psychologin und Paartherapeutin Gesprächspartnerin: Jessica Frampton, Assistenzprofessorin an der School of Communication Studies, University of Tennessee, Knoxville**********Quellen:Jessica R. Frampton and Jesse Fex (2018). Social Media's Role in Romantic Partners' Retroactive Jealousy: Social Comparison, Uncertainty, and Information Seeking.Blayney, R., & Burgess, M. (2024). Identifying points for therapeutic intervention from the lived experiences of people seeking help for retroactive jealousy. Counselling and Psychotherapy Research, 24, 591–599.**********Ihr könnt uns auch auf diesen Kanälen folgen: TikTok auf&ab , TikTok wie_geht und Instagram .**********Meldet euch!Ihr könnt das Team von Facts & Feelings über WhatsApp erreichen.Uns interessiert: Was beschäftigt euch? Habt ihr ein Thema, über das wir unbedingt in der Sendung und im Podcast sprechen sollen?Schickt uns eine Sprachnachricht oder schreibt uns per 0160-91360852 oder an factsundfeelings@deutschlandradio.de.Wichtig: Wenn ihr diese Nummer speichert und uns eine Nachricht schickt, akzeptiert ihr unsere Regeln zum Datenschutz und bei WhatsApp die Datenschutzrichtlinien von WhatsApp.
In a special bonus episode, on the eve of the SheBelieves Cup, our resident women's football expert, Alex Bishop, catches up with new Nadeshiko Japan assistant coach, Leah Blayney. Together they discuss her coaching journey in Australia, her first impression of the Japanese players and the emotion of coming up against Australia in her first game. Be sure to follow The Asian Game on all our social media channels: X: https://twitter.com/TheAsianGame IG: https://instagram.com/theasiangame Facebook: https://facebook.com/TheAsianGamePodcast
Scott Sattler and Tyrone Peachey are joined by Penrith Panthers forward Liam Henry as the club prepares for their Las Vegas round 1 clash against Cronulla! Learn more about your ad choices. Visit megaphone.fm/adchoices
In this enlightening episode of The Patient From Hell podcast, Dr. Doug Blayney and host Samira Daswani dive deep into the key insights from the 2024 San Antonio Breast Cancer Symposium (SABCS). They explore four critical areas of breast cancer care: CDK4/6 inhibitors, antibody-drug conjugates (ADCs), de-escalation strategies for ductal carcinoma in situ (DCIS), and the emerging role of artificial intelligence in cancer diagnostics. Throughout the conversation, a central theme emerges: the increasing ability to personalize cancer treatment, considering individual patient characteristics, biological markers, treatment options, and personal goals for quality and quantity of life. Key Highlights: 1. Biomarkers are becoming increasingly sophisticated, allowing for more precise and personalized treatment approaches across different breast cancer subtypes. 2. Patient choice and individual considerations are paramount, with treatment decisions now focusing on balancing potential survival benefits against quality of life impacts. 3. Emerging technologies like antibody-drug conjugates and artificial intelligence are revolutionizing breast cancer care by offering more nuanced, targeted diagnostic and treatment options. About our guest: Dr. Doug Blayney is an oncology physician who specializes in breast cancer and the Chief Medical Officer of Manta Cares. His research focuses on quality improvement in cancer care systems, new drug development, and patient experience improvement. At the American Society of Clinical Oncology (ASCO), he was founding Editor-in-Chief of its flagship practice journal, and as President, started the ASCO Quality Symposium and began planning for ASCO's CancerLinq. He was a founding member of the National Comprehensive Cancer Network (NCCN) Growth Factor Guideline panel, and is a past member of the U.S. Food and Drug Administration's Oncology Drugs Advisory Committee and the NCCN Board of Directors. Key Moments: At 38 minutes: "There's a company now that has a gene expression panel that may predict, and it looks like it does predict, whether radiation treatment after standard treatment for DCIS is beneficial. So if this predicted biomarker of benefit for radiation pans out, and I think it probably will, that means that we can deescalate or personalize whether radiation treatment and its side effects are likely to be beneficial to that patient." At 45 minutes: "Quality of life, can that be answered by a nine question questionnaire? Well, maybe. If you can't get out of bed, your quality of life is because something hurts or if your arm doesn't work because they're so swollen, that's one extreme... What about 15 years playing that duet? What about three? It's those kind of subtleties that we need to take into account." At 49 minutes:"AI can interpret mammograms. The images from a mammogram 20 years ago, there were four, top, bottom, side, side, and maybe another oblique. And now there's 60 images from a mammogram. So that means that a radiologist, a human radiologist, whether it's next door or around the world, somebody needs to look at those. AI can help." Disclaimer: All content and information provided in connection with Manta Cares is solely intended for informational and educational purposes only. This content and information is not intended to be a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
A $1 billion gold mine. A sacred story about a beautiful native bee. And a giant drama enveloping Tanya Plibersek and opposing groups of Wiradjuri elders. Find out more about The Front podcast here. You can read about this story and more on The Australian's website or on The Australian's app. This episode of The Front is presented by Claire Harvey, produced by Kristen Amiet, and edited by Jasper Leak. The multimedia editor is Lia Tsamoglou, and original music is composed by Jasper Leak. See omnystudio.com/listener for privacy information.
Did aliens land at a small Welsh school in 1977? Believe? is a podcast all about the world's craziest conspiracy theories, or are they crazy? Each episode comedians Phil Green and David Ferguson invite a guest to pick their favourite conspiracy theory and then try to make sense of it. In this episode we're joined by actor, comedian and bonafide Welshman Carwyn Blayney to try and uncover the truth behind the mysterious UFO sightings in western Wales in the 1970s. Other important topics covered are jokes at a funeral, vocal fry and French longwave radio.Follow us on Insta @believeconspiracypodcastFollow us on TikTok @believeconspiracypodcastWatch on YouTube https://www.youtube.com/@believeconspiracypodcastFollow Carwyn @carwynblayneyFollow Phil @philgreencomedyFollow David @lovedavidfergusonSee Phil's live shows https://linktr.ee/philgreencomedySee David's live shows https://linktr.ee/lovedavidferguson Hosted on Acast. See acast.com/privacy for more information.
Nationals MP Sam Farraway has called on the MP to step in over Environmental Minister Tanya Plibersek's decision to implement section 10 on the Blayney gold mine and a stretch of road. See omnystudio.com/listener for privacy information.
Throughout her entire life Shana Blayney has gone to Sunday Mass and shared Sunday meals with her family. So simple, yet so powerful. From the time Shana was small she's experienced the living witness of her parents, who have religiously attended Mass and hosted family dinners on Sundays. Shana now has a family of her own and they, along with her siblings and their families, spend Sundays at Mass and at Shana's parents' home sharing meals. In this encouraging podcast, Shana shares how she has experienced the fruit of obedience: love. Her family has gathered throughout all seasons of life, both the joyful and sorrowful, just to be together. Listen to Shana share and be inspired to root your own life in the Eucharist and family meals (even if this means friends who become family!).
In this episode of Southeastern Fly, we dive into the rich fishing landscape of Western North Carolina with Nathan Faggard and Blayney Del Priore, owners of Ashe Anglers. Join us as we explore the journey of these young guides, their favorite fishing spots, and the diverse species they target. From wild trout in the high elevations to smallmouth bass in the New River, this episode is packed with valuable insights for anglers of all levels.Key Highlights:Starting a Guiding Business: Nathan and Blayney share their journey from passionate anglers to business owners, highlighting the challenges and joys of guiding in Western North Carolina.Fishing Opportunities: Discover the variety of fishing environments in the region, including tailwaters, the Smokies, and Cherokee, and learn about the diverse species available, from trout to smallmouth bass.Personal Fly Fishing Histories: Hear how Nathan and Blayney fell in love with fly fishing, their early experiences, and how they rekindled their passion over the years.Wild Trout Fishing: Gain insights into the unique challenges and rewards of targeting wild trout in Western North Carolina, including tips on finding fish and understanding local ecosystems.Stocked vs. Wild Trout: Learn about the differences between fishing for stocked and wild trout, including strategies for each and the gear you'll need.Smallmouth Bass Fishing: Explore the thrill of smallmouth bass fishing in the New River, including the best times of year, effective techniques, and gear recommendations.Fishing Techniques and Gear: Nathan and Blayney share their favorite rod setups, flies, and gear for different fishing scenarios, emphasizing the importance of adaptability and understanding local conditions.The Ones That Got Away: Hear memorable fishing stories from Nathan and Blayney, reflecting on the big catches that slipped away and the lessons learned from those experiences.Local Recommendations: Get tips on the best places to eat and drink in Western North Carolina, including local breweries and must-visit restaurants in Boone and West Jefferson.Tune in to this episode of Southeastern Fly and get inspired to explore the beautiful fishing opportunities in Western North Carolina with the expert guidance of Ashe Anglers. Whether you're a seasoned angler or just getting started, Nathan and Blayney's insights and stories will help you make the most of your next fishing adventure.Listen to the episode and happy fishing!Produced by NOVA Media
Scott Sattler and Mat Rogers are joined by Penrith Panthers utility Liam Henry who touches on his childhood in Blayney, what he's learning from the senior playing group and Nathan Cleary's on-field presence! Learn more about your ad choices. Visit megaphone.fm/adchoices
In this episode, Dr. Doug Blayney, oncologist, former President of the American Society of Clinical Oncology (ASCO), and the Chief Medical Officer of Manta Cares, discusses the latest advancements in breast cancer treatments presented at ASCO's 2024 Annual Meeting. He highlights the significant progress in antibody drug conjugates (ADCs), which are engineered to specifically target cancer cells, offering new hope in cancer treatment. The Manta Cares team also attended the ASCO conference, presenting an abstract for a personal treatment management tool designed to assist cancer patients and survivors (and their families!) in navigating their next steps – Manta Maps! For more information, visit our website here and join the list to request access to the digital platform this fall here. Key Highlights: 1. Advancements in breast cancer treatment were highlighted at the ASCO Annual Meeting this year, including alternatives to chemotherapy and the emergence of antibody drug conjugates (ADCs). 2. Checkpoint inhibitors help the immune system recognize and attack cancer cells by removing the "brakes" that prevent the immune system from targeting the cancer. 3. Personalized approaches to treatment based on patient age, co-morbidities, and cancer type, were highlighted, leading to more effective and tailored treatments. About our guest: Dr. Doug Blayney is an oncology physician who specializes in breast cancer. His research focuses on quality improvement in cancer care systems, new drug development, and patient experience improvement. At the American Society of Clinical Oncology (ASCO), he was founding Editor-in-Chief of its flagship practice journal, and as President, started the ASCO Quality Symposium and began planning for ASCO's CancerLinq. He was a founding member of the National Comprehensive Cancer Network (NCCN) Growth Factor Guideline panel, and is a past member of the U.S. Food and Drug Administration's Oncology Drugs Advisory Committee and the NCCN Board of Directors. Dr. Blayney leads the Manta Cares Scientific Advisory Board as the Chief Medical Officer. Key Moments: At 1:05 "As a doctor who treats breast cancer, I thought it was important that we have a lot of alternatives to chemotherapy. So even though some of the studies were portrayed as negative because they didn't improve overall survival, I think pushing out the time a patient gets chemotherapy and its associated toxicities is a major advance.” At 21:14 "We need better assays to predict who's going to respond to these ADCs (Antibody Drug Conjugates). We're learning that they're here to stay and they're a great benefit to many with breast cancer and other cancers." At 35:20 “It's thought that you and people without known cancer, develop one or two cancers a day, small little bitty ones and our body's immune system recognizes that as foreign and eats them up and the cancer doesn't grow and proliferate. One of the ways cancer grows, especially in adults, is immune escape. So somehow the brakes are put on the immune system at some point when that cancer develops. The IO checkpoint inhibitors are thought to work by taking off those brakes.” Visit the Manta Cares website Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard, or delay in obtaining, medical advice for any medical condition they may have, and should seek the assistance of their health care professionals for any such conditions. --- Support this podcast: https://podcasters.spotify.com/pod/show/manta-cares/support
Panthers forward Liam Henry joins Vossy and Brandy to discuss rugby league, his early life in Blayney and his favourite chinese dishes Learn more about your ad choices. Visit megaphone.fm/adchoices
Panthers forward Liam Henry joins Vossy and Brandy to discuss rugby league, his early life in Blayney and his favourite chinese dishes Learn more about your ad choices. Visit megaphone.fm/adchoices
'How do you get your ideas?' If this seems a silly question to you: try not to say that. Think ahead and make up a reason. You're a creator! 'How do you get your ideas?' If this seems a silly question to you: try not to say that. Think ahead and make up a reason. You're a creator! Invent. And if your audience is bijou — shall we say — involve them.
In this episode I am joined by Cam Scorey. Cam owns and operates Hussln Auto Detailing out of Tatura in regional Victoria. After chatting back and forth for a long time with Cam via social media, it was great to be able to pay him a visit and record this episode face to face at his facility located on the busiest intersection in town. In this episode we got to hear about how Cam started out in detailing and how he went from working for a dealership to taking the leap and opening his own business and later on moving into a workshop of his own. We got to hear about Cam moving from Shepparton to Papua New Guinea when he was a week old where he would live for 5 years with armed security and what that was like trying to make friends. Then on to regional NSW in Blayney into his teen years before moving back home to regional Victoria. We also got to hear about how Cam moved to Perth for a girl he met online which ultimately led him to start detailing, and marry his wife before moving back to Victoria again. Cam has a really cool story and I'm glad that I had the opportunity to sit and talk with him for this episode. You can find Cam on: Website: https://husslnautodetailing.com.au/ Facebook: https://www.facebook.com/profile.php?id=100063785523815&sk=about Instagram: https://www.instagram.com/hussln_auto_detailing/?hl=en Don't forget to follow the podcast on: Instagram: https://www.instagram.com/gutter2gutterpodcast/ Facebook: https://www.facebook.com/G2GPodcast/ TikTok: https://www.tiktok.com/@gutter2gutter Patreon: https://www.patreon.com/gutter2gutterpodcast Please also rate and review on your podcast platform of choice and be sure to tell a friend about us. This is a great way to help us grow and reach more earholes. I'd like to send a massive thank you to our Gutter 2 Gutter Podcast Patreon supporters! AJ Hoad Lonely Drivers Driving Club Shifting Through The Gears
Getting reviews and reader feedback can be difficult. The Pigeonhole is a new way to transform your relationship with your readers.
The post 15 Oct 23 – Richard Blayney appeared first on Carrickfergus Baptist Church.
Athlete of the Month with Park National Bank: https://www.richlandsource.com/2023/09/08/ontarios-yugovich-is-augusts-park-national-bank-athlete-of-the-month/ Today - As the school year gets going, Richland Source, Ashland Source and Knox Pages are excited to announce a new partnership with Park National Bank… Athlete of the month!Support the show: https://www.sourcemembers.com/See omnystudio.com/listener for privacy information.
Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2023.07.21.549845v1?rss=1 Authors: Jaulim, A., Cassidy, L. D., Young, A. R. J., Chan, A. S. L., Warren, A. Y., Taylor, A. E., Arlt, W., Lan, G., Blayney, M. L., Davidson, O., Barratt, C. L. R., Pacey, S., Narita, M. Abstract: Autophagy has been implicated in male fertility but its specific role in the post-testicular organs remains unclear. Here, we investigate this in mice expressing a doxycycline-inducible RNAi against Atg5 (Atg5i). Systemic autophagy inhibition in Atg5i mice resulted in the morphological and functional abrogation of the male accessory sex organs, leading to male subfertility. However, the testis was largely protected, likely due to the limited permeability of doxycycline through the blood-testis barrier. Interestingly, restoration of autophagy by doxycycline withdrawal in Atg5i mice led to substantial recovery of the phenotype in the accessory organs. This model offers a unique opportunity to dissect the pre- and post-testicular roles of autophagy, highlighting the non-autonomous impact of autophagy on male fertility. Copy rights belong to original authors. Visit the link for more info Podcast created by Paper Player, LLC
Dr. Douglas Blayney, past ASCO president and oncologist, gives us his thoughts on some of the key scientific themes presented at the 2023 ASCO annual meeting. In the field of breast cancer, there are three key areas of interest Dr. Blayney discusses. First, there is growing attention towards the use of CDK 4/6 inhibitors in the treatment of hormone positive breast cancer. Second, the significance of somatic cell DNA testing is being recognized. This testing can inform treatment decisions at different stages of the disease and help identify when a change in treatment is necessary. Lastly, there is a focus on the emerging role of antibody drug conjugates, which can selectively kill cancer cells in a more targeted way. Samira and Dr. Blayney also discuss how patients learn from and use this new information in partnership with their physician. Key Highlights: What are CDK 4/6 inhibitors and why are they important? How can genetic testing inform cancer treatment plans? How do physicians and patients think about and integrate new scientific findings? About our guest: Dr. Doug Blayney is an oncology physician who specializes in breast cancer. His research focuses on quality improvement in cancer care systems, new drug development, and patient experience improvement. At the American Society of Clinical Oncology (ASCO), he was founding Editor-in-Chief of its flagship practice journal, and as President, started the ASCO Quality Symposium and began planning for ASCO's CancerLinq. He was a founding member of the National Comprehensive Cancer Network (NCCN) Growth Factor Guideline panel, and is a past member of the U.S. Food and Drug Administration's Oncology Drugs Advisory Committee and the NCCN Board of Directors. Dr. Blayney leads the Manta Cares Scientific Advisory Board. Key Moments: 8 minutes: What is a CDK 4/6 inhibitor? “When that estrogen receptor growth pathway is shut down, the cell compensates, or many of the cancer cells compensate by this CDK 4/6 pathway. And it turns out that if you combine estrogen blockade with blockade of the CD46 pathway at various steps, you can have an augmented or more effective therapeutic approach.” 18 minutes: On the types of DNA and how they impact cancer treatment decisions: “There are two kinds of DNA. There's germline DNA, which is present in every cell in our body. Then there is somatic mutation, which happens to various cells. Whether it's in a breast cell or a lung lining cell or a colon lining cell, an accumulation of those mutations in the right spot can lead to a cancer.” 33 minutes: On thinking about decision making with new scientific advances: “Your listeners may remember that 20 or 30 years ago, randomized clinical trial looked at circulating tumor cells monitoring versus standard monitoring. And the circulating tumor cell DNA did not improve survival, probably because of the sensitivity of the test. Plus the treatments 20 or 30 years ago weren't as efficacious. There weren't as many of them. So if the cancer was growing, but you didn't have an effective treatment for it, so what? Looking at this now, the situation has changed. The test is probably more sensitive, and we have more treatments.” Visit the Manta Cares website Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard, or delay in obtaining, medical advice for any medical condition they may have, and should seek the assistance of their health care professionals for any such conditions. --- Support this podcast: https://podcasters.spotify.com/pod/show/manta-cares/support
There is a lot of buzz around the annual ASCO meeting, which brings together 40,000 oncology professionals from around the world. But as a patient, what does that mean for us? Dr. Douglas Blayney, past ASCO president and oncologist gives us a behind the scenes understanding of the purpose, process and outcomes that are driven by the information shared at the ASCO annual meeting. He shares how different stakeholders in the oncology and healthcare ecosystem play a role at the meeting, and how the information is used to improve patient care and also drive innovation. Key Highlights: What brings 40,000 people to Chicago for the ASCO annual meeting? How does the scientific information presented at ASCO impact patients and the public? The importance of transparency and trust in presenting scientific findings. About our guest: Dr. Doug Blayney is an oncology physician who specializes in breast cancer. His research focuses on quality improvement in cancer care systems, new drug development, and patient experience improvement. At the American Society of Clinical Oncology (ASCO), he was founding Editor-in-Chief of its flagship practice journal, and as President, started the ASCO Quality Symposium and began planning for ASCO's CancerLinq. He was a founding member of the National Comprehensive Cancer Network (NCCN) Growth Factor Guideline panel, and is a past member of the U.S. Food and Drug Administration's Oncology Drugs Advisory Committee and the NCCN Board of Directors. Dr. Blayney leads the Manta Cares Scientific Advisory Board. Key Moments: 9 minutes - On what's important about the ASCO annual meeting: “The ASCO annual meeting has a long tradition of having breakthrough therapies announced. Traditionally, on Sunday afternoon, the highest impact scientific findings are announced in the plenary session, which this year had four abstracts featured.” 27 minutes - On the importance of scientific meetings for clinicians and patients: “Most clinicians and oncologists want to do the best for our patients. Having said that, we can't be everywhere, and we can't know everything, so we do rely on other sources of information, maybe secondary or tertiary sources of information about what went on at the ASCO meeting and other scientific meetings.” 33 minutes - On the integrity of scientific data presented at ASCO: “ASCO is a largely volunteer professional society, with the exception of the elected officers, or actually the president and board chair, etc. So three or four elected officers and the journal editors are compensated, and all other ASCO activities are essentially donated by interested parties. And part of the American tradition, as de Tocqueville pointed out in the early 1800s, is that there's this large tradition of volunteerism in our society, which is great and very satisfying. And which ASCO takes advantage of and gives a very positive outlet for clinicians, doctors, and other advocates who want to volunteer to make the world better. Visit the Manta Cares website Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard, or delay in obtaining, medical advice for any medical condition they may have, and should seek the assistance of their health care professionals for any such conditions. --- Support this podcast: https://podcasters.spotify.com/pod/show/manta-cares/support
Media Watch 2023 Episode 17: Nine's Modi mania; Taser tragedy; Blayney family affair.
Colossians 2:6-23 6which has come to you, as indeed in the whole world it is bearing fruit and increasing—as it also does among you, since the day you heard it and understood the grace of God in truth, 7just as you learned it from Epaphras our beloved fellow servant. He is a faithful minister of Christ on your behalf 8and has made known to us your love in the Spirit. 9And so, from the day we heard, we have not ceased to pray for you, asking that you may be filled with the knowledge of his will in all spiritual wisdom and understanding, 10so as to walk in a manner worthy of the Lord, fully pleasing to him: bearing fruit in every good work and increasing in the knowledge of God; 11being strengthened with all power, according to his glorious might, for all endurance and patience with joy; 12giving thanks to the Father, who has qualified you to share in the inheritance of the saints in light. 13He has delivered us from the domain of darkness and transferred us to the kingdom of his beloved Son, 14in whom we have redemption, the forgiveness of sins. The Preeminence of Christ 15 He is the image of the invisible God, the firstborn of all creation. 16For by him all things were created, in heaven and on earth, visible and invisible, whether thrones or dominions or rulers or authorities—all things were created through him and for him. 17And he is before all things, and in him all things hold together. 18And he is the head of the body, the church. He is the beginning, the firstborn from the dead, that in everything he might be preeminent. 19For in him all the fullness of God was pleased to dwell, 20and through him to reconcile to himself all things, whether on earth or in heaven, making peace by the blood of his cross. 21 And you, who once were alienated and hostile in mind, doing evil deeds, 22he has now reconciled in his body of flesh by his death, in order to present you holy and blameless and above reproach before him, 23if indeed you continue in the faith, stable and steadfast, not shifting from the hope of the gospel that you heard, which has been proclaimed in all creation under heaven, and of which I, Paul, became a minister.
Colossians 1:15-23 15 He is the image of the invisible God, the firstborn of all creation. 16For by him all things were created, in heaven and on earth, visible and invisible, whether thrones or dominions or rulers or authorities—all things were created through him and for him. 17And he is before all things, and in him all things hold together. 18And he is the head of the body, the church. He is the beginning, the firstborn from the dead, that in everything he might be preeminent. 19For in him all the fullness of God was pleased to dwell, 20and through him to reconcile to himself all things, whether on earth or in heaven, making peace by the blood of his cross.21 And you, who once were alienated and hostile in mind, doing evil deeds, 22he has now reconciled in his body of flesh by his death, in order to present you holy and blameless and above reproach before him, 23if indeed you continue in the faith, stable and steadfast, not shifting from the hope of the gospel that you heard, which has been proclaimed in all creation under heaven, and of which I, Paul, became a minister.
It's time for your weekly taste of Dub Zone as we bring you interview highlights from last week's episode. Joining the Dub Zone crew during Round 14 were Wanderers coach Kat Smith, Western United defender Sydney Cummings, Young Matildas coach and good friend of the podcast Leah Blayney & Matildas forward Larissa Crummer. To never miss a second of Dub Zone, tune in live from 2.45pm (AEDT) every Saturday on 10 Play, 10 Football and A-Leagues Facebook.See omnystudio.com/listener for privacy information.
Poet, journalist and mentor Mark Blayney chooses the eight items he would take with him, if he was about to be marooned on a desert planet Photo by Dave Daggers
KEEPUP's Campbell Johnson is joined by Western Sydney Wanderers midfielder Amy Harrison and Young Matilda's coach Leah Blaney to talk through another massive round of the Liberty A-League. The panel talk about the impact of the international players this season in the Liberty A-League and the pressure that comes with being a player from overseas in Australia. They also discuss: How losing a game for one team might bring some benefits for the rest of the season. The fantastic story of a childhood dream come true for Paige Zois & Alana Jancevski. The Wanderers big win against City and how that will bring momentum this weekend against a still perfect Western United. The form of Lauren Allan and whether she has been flying under the radar so far this season. Join us every week on the Liberty A-League Podcast as we look back at the talking points from each weekend & more.See omnystudio.com/listener for privacy information.
Australia's longest-running women's football podcast (est. April 2019). History: Leah Blayney, Matildas Cap 126 Matildas Debut: 2004 (played for the national team until 2006)Grassroots Club: Wentworth Falls UnitedAppearances: 16Position: Midfielder Hot Topics News APL announce that the next three A-League Women Grand Finals will be held in Sydney, regardless of the participating teams (we are not impressed) Latest FIFA rankings: Full list of WNT rankings APL released their report for 2020-22 New Zealand will play two games against Argentina in February Canadian professional league to be launched in 2025 Philippines are holding a training camp at Wanderers Football Park Is Angie Beard switching to the Philippines? Vivianne Miedema spent time in Adelaide last month and Aussie woso fans missed it! Long-time ALW commentator Teo Pellizzeri praised our humble little podcast :) Matildas Matildas to play pre-WWC friendly in Melbourne on July 14 Women's World Cup training venues announced Dub News & Signings Round 4 Review Round 5 Preview Season 15 squad page Around the World UEFA Champions League UK Conti Cup FA WSL FA Cup Europe France - D1F (11 of 22) Italy - Serie A (12 of 18) Germany - Frauen Bundesliga (10 of 22) Queens / Kings / Legends of the Week Siofane Boufal's mum Robbie Szafranek Teddy from Matildas Active Support Lia Walti and Leah Williamson Christine Sinclair and Diana Matheson
In this episode, Neil chats to visual artist, specialising in quirky and colourful animals, Tracey Mackie from Blayney in New South Wales. Local Government Area: Blayney Website: www.traceymackieartist.com This episode is proudly supported by our season sponsor - Nufarm. Australian Through and Through. Visit their web site at www.nufarm.com.au
Hey Dude, I riff and ramble about Howard Hughes and his dirty fingerprints all over the 20th century. I also admit to going on a 48 hour binge of The Americans. QUOTE: "Another time, another dime." PEOPLE: Ray Liotta, Edward Albee, James Ellroy, Howard Hughes, JKF, RFK, Larry O'Brien, Richard Nixon, Robert Maheu, Blayney F. Matthews, J.L. Warner, Keri Russell PLACES: Watergate Hotel, Iowa, California, Shoreline Village, Long Beach THINGS: The Goat, or Who Is Sylvia, American Tabloid, Watergate, Larry O'Brien Championship Trophy, DNC, aviation TV/FILM: Once Upon a Time in Hollywood, Licorice Pizza, The Sopranos, The Many Saints of Newark, The Americans, Mission Impossible, Warner Bros., Felicity SOUNDS: footsteps, gravel path, jet, birds, Laguna Sawdust Cowbell Chimes GENRE: storytelling, personal narrative, personal journal PHOTO: "Shoreline Village Chimes" iPhone XS RECORDED: May 29, 2022 from the "Wawona Lawn" under the flight path of the Bob Hope Airport in Burbank, California GEAR: Sony ICD PX370 digital voice recorder and Sony ECM CS3 "tie-clip" microphone. HYPE: "It's a beatnik kinda literary thing in a podcast cloak of darkness." Timothy Kimo Brien (cohost on Podwrecked and host of Create Art Podcast) DISCLAIMER/WARNING: Proudly presented rough, raw and ragged. Seasoned with salty language and ideas. Not for most people's taste. Please be advised.
FULL REPLAY: FOOTBALL OUT WEST SHOW - PODCAST Western suburbs coaching legend Micky Colina joined Melbourne Victory Women's coach Jeff Hopkins and Young Matildas coach Leah Blaney on this week's Show! NEWLY appointed FC Strathmore Split coach MICKY COLINA appeared on this week's Football Out West Show. It was the former Dandenong City coach's first media appearance since taking over the Croatian community-backed Victorian State League 1 side. He was joined by 2021/22 Women's A-League champions Melbourne Victory Head Coach JEFF HOPKINS plus the Football Australia U20's Young Matildas Head Coach LEAH BLAYNEY as we discussed everything related to the female side of the game. This week's show was sponsored by the award-winning Georgies on Vista, the home of Caroline Springs George Cross FC.
Royce Simmons is an Australian former NRL Player & Coach. During his playing career he represented the Penrith Panthers, NSW Blues and Australian Kangaroos. After he finished playing he moved into the coaching world and ended up coaching the Panthers, Hull FC, St Helens and later worked as an assistant coach to Tim Sheens at Wests Tigers. When Penrith Panthers' rugby league legend Royce Simmons disclosed in January 2022 that, at age 61, he had been diagnosed with dementia the previous year, many were in shock.Typically, the former Kangaroos hooker immediately set about not only exploring what he required to do to slow the dreaded condition's progress, his thoughts turned to assisting others who were affected by the disease – not just sufferers but their supporting families too.Within months, Royce's Big Walk (a registered charity foundation) as a reality and the support he has received by not just many VIPs of rugby league, but the Penrith district's community and beyond has been extraordinary.So, among other fund-raising initiatives for Royce's designated not-for-profit support organisation, Dementia Australia, Royce will walk – from May 17-26 – the 300km from his small hometown of Gooloogong (population less than 300) through Cowra, Carcoar, Blayney, Bathurst, Katoomba and across the Blue Mountains, arriving pre-match at Penrith's Bluebet Stadium the night the Panthers take on North Queensland Cowboys.Along the way there will be several sportsman's dinners or lunches, and a coaching clinic, to help raise funds for local rugby league on the route.You can support Royce's mission, Dementia Australia, junior rugby league and, in particular, the families who have or will go through what Royce himself is confronting, by donating or attending some of the functions from May 17-26.The tough-as-nails former Panthers skipper is tackling his Alzheimer's diagnosis just as he would any other opponent on the footy field – head on and with the benefit of his ‘team' and their supporters as his major priority.If you would like to donate and support Royce please visit the link below. https://www.memorywalk.com.au/event/royces-big-walk
I have been a fan of Jeff Black's songwriting for many years. He was born in Kansas City, Missouri and grew up in Liberty, Missouri. In the 1980's Black began performing at Blayney's, a blues club here in Kansas City where he also worked as a bouncer. Jeff began touring and eventually relocated to Nashville where he re-connected with Kansas City friend, Iris Dement lending some backing vocals on DeMent's 1992 debut album, Infamous Angel). Black's own first album, Birmingham Road, was recorded with the members of the band Wilco, minus lead singer, Jeff Tweedy. Those songs have been described as "fine portraits of American life without the sappiness or self-consciousness often attributed to the singer/songwriter genre.” Sam Bush has championed him with recording many of his songs including "Same Ol' River" and "King Of The World". Jeff co-wrote the title track to Sam's Grammy nominated album "Circles Around Me". His songs appear on recordings by Alison Krauss, Waylon Jennings, Jerry Douglas, Dierks Bently, John Oates, Blackhawk, Jo-el Sonnier and the soundtracks of "The Thing Called Love" The acclaimed PBS documentary "The Appalachians" and Sundance Film Festival's Grand Jury Prize Winner "Steel City". WUMB Boston listeners voted Black one of the top 100 Folk artists of the last 25 years. His intimate live shows provide a master class in songcraft appreciation, tempo and audience interaction. After a two year pandemic induced hiatus, I was finally able to welcome Jeff back into the KKFI studios for a sit down conversation and private mini concert in support of some recent Midwest gigs. We talked about music education, or the lack thereof, the pandemic, of course, collaboration, mentorship and the value (or not) of songwriting workshops. Enjoy this musical conversation and performance with the lyrical and very talented Jeff Black.
In this episode, recorded in November 2021, Gary Cole speaks with Leah Blayney. Leah is the Head Coach of the Young Matildas and the Future Matildas, which she combines with teaching at Westfield Sports High. Her love for the game began in the Blue Mountains in New South Wales with Wentworth Falls Warriors, and then Macarthur Rams U14 Boys, where she was the only girl in the team. Leah headed to College in the USA and that's where she started her coaching journey. Her playing career saw her play professionally in Australia, USA and Sweden. She also played for the Young Matildas and the Matildas before her playing career was cut short by injury. She has coached with Football New South Wales and the National Talent Centre (NTC) Program, has been Assistant Coach with West Sydney Wanderers, Assistant Coach of the Matildas, and was also included in the Football Australia Female Coach Mentor Programs. Leah went to the Rio Olympics and the World Cup in France as a scout/analyst. Leah took over from Gary Van Egmond as Young Matildas Coach in 2019 and took them to the AFC U19 Championship. She is now busy preparing the team after the 2022 Asian Cup in Uzbekistan was cancelled due to Covid. She talks frankly about developing young players and the importance of tournaments and game time for fringe Matildas. Empowering female coaches as well as players is high on Leah's to do list. Please join Gary Cole in this journey into Leah Blayney's Football Coaching Life.
FCA Podcast With Gary Cole & Leah Blayney Friday 12 Nov 2021 by Ralph Barba
Young Matildas Coach joins Simon and Brosquey to review the Matildas 2-game series - with crowds of over 10,000 present for the 2 fixtures at CommBank Stadium.
The Matildas are in action tonight against Brazil, the first time they've played on home soil in 2 years. Calling all the action for SEN is Leah Blayney who joined Jason Matthews on Sports Central.
Part of the SEN Commentary team this weekend alongside Adam Peacock, Leah Blayney joined the show to preview the Matildas v Brazil match this Saturday.
The S&P/ASX200 closed up 29 points or 0.4% on Wednesday hitting 7,532 and crossing above its 20-day moving average and is only 1.3% off of another record high. Stateside, the S&P 500 notched its own half-century of record closes in 2021 and the Nasdaq topped 15,000 for the first time. Here at home the materials and IT sectors following suit. Wednesday's top performers, WiseTech Global (WTC) and Appen (APX), up 28% and 9% respectively - the former copping a speeding ticket before lunchtime when it was up around 50% in the space of 90 minutes.Our top three VODs: Afterpay's future is a fusion of payments, commerce and finance to serve the next genWhy Scentre Group is a buyWednesday reporting season wrestle: Hook vs Blayney in a buy, hold and sell to the death See acast.com/privacy for privacy and opt-out information.
With a recent lockdown affecting the Orange and Blayney areas, we discuss our experience of lockdown and the effect that COVID is currently having in NSW and throughout Australia. With the Census coming up and the National Church Life Survey around the corner, we discuss the importance of good data. Pope Francis recently released a video discussing his prayer intention for August. We discuss this and evangelisation more generally. Finally, we are joined by Melinda Dwight to discuss her journey of faith and Alpha. You can contact us at podcast@bathurst.catholic.org.au or hit like on our Facebook page. Opening Theme Music: Derek Clegg - A Strong Will is Needed - Used under Creative Commons. Editing & Cover Art by Emily Bennett
In this episode Blayney comes on the podcast to share both of her birth stories! Her first pregnancy was a huge surprise... TWINS! Her pregnancy was uncomplicated, she was planning a vaginal twin birth at first, and carried to almost 38 weeks! For Blayney's second pregnancy she planned for a VBAC (vaginal birth after cesarean) with her midwife and doula. After almost 3 days in labor she had an amazing unmedicated VBAC! A few key things we mention in this episode are Nitrous Oxide use, the fetal ejection reflex, a retained placenta, and a postpartum D&C. ____________________ If you enjoyed this episode please subscribe and share with your mama friends! wanna be on the podcast? https://www.whatthebumpclt.com/podcast connect with me on Instagram: https://www.instagram.com/whatthebumpclt/ our website / blog: whatthebumpclt.com --- Support this podcast: https://anchor.fm/what-the-bump/support
A lockdown in the Orange, Blayney and Cabonne local government areas is the first time a stay-at-home order has been imposed in regional NSW.
Parts of regional New South Wales are facing tougher coronavirus restrictions from today [[July 21]], including stay-at-home orders. The stricter health measures apply to the Orange City Council, Cabonne [[kuh-BON]] council and Blayney [[blay-nee]] Shire, and to anyone who was thereafter the 17th of July.
Orange, Cabonne and Blayney councils placed into a seven day lockdown after pet food factory worker returns positive covid test
On today's episode Matt sits down with a premier Australian booking agent, his good friend Anthony Blayney. They talk about touring in Australia, the reasons behind doing this and so much more! Find out what Anthony's been up too via the Your Mate Instagram: https://www.instagram.com/yourmatebookings/ Learn more about your ad choices. Visit megaphone.fm/adchoices
Brannockstown Baptist Church has a long and rich history. It was founded around 1870 by John La Touche, master of the Harristown estate (the La Touches were wealthy and influential aristocrats in France until the Huguenot expulsion). John La Touche became a Christian and was baptised by the well-known Rev. C. H. Spurgeon at the Metropolitan Tabernacle in London. Wishing to share the good news of Jesus and call people to follow him, John gathered a small congregation, which in its infancy met in a cottage in the village. In 1882 a gothic chapel of limestone and red sandstone was erected, followed in due course by the manse next door. John La Touche taught and cared for the church family, and later made provisions for the continuation of the church following his death in 1904. This episode interviews the current pastor of Brannockstown, Richard Blayney, about the rich history of the church. Richard is married to Steph, and they have three children. He comes from Coleraine and went to Brannockstown following studies at the Irish Baptist College. A short presentation on the history of the church by Richard Blayney was also recorded on the occasion of the church's 150th anniversary for the Irish Baptist Historical Society and can be viewed at https://youtu.be/GU7pZ4Px0ec
Michael is joined by Andrew Gee MP, federal member for Calare & Minister for Decentralisation & Regional Education, who has accused the big four of betraying loyal rural customers. Minister Gee says, ‘While the Government is working to promote decentralisation and the growing trend to move to the regions, the banks are actively undermining this with a deliberate plan to close country branches.' ‘It is quite clear that both the Molong and Blayney districts are still profit centres for the bank, and that these branches are being closed merely to boost profits for the bank's shareholders.' ‘As a further blow, executives from the Commonwealth Bank only intend to visit Blayney and Molong almost two weeks after their intended closure date of 4 June. This is a slap in the face to the local Commonwealth Bank customers.' ‘These bank closures are a huge issue in regional Australia and we need to fight them, so that our country communities are not left behind, while the big four banks line their ever-increasing back pockets.' See omnystudio.com/listener for privacy information.
With over 40 years' experience in mining operations and mineral processing, Tony has worked in and led both open cut and underground operations around Australia. Tony commenced his career as a motor mechanic, before progressing to maintenance and then onto operations management at various companies, including CRA, Denehurst, Mount Isa Mines, and Newcrest. More recently, Tony joined Regis Resources as Manager of Special Projects working on the proposed McPhillamys Gold Project at Kings Plains, near Blayney. If approved, the McPhillamys project would consist of an open cut gold mining operation that has a current project life of approximately fifteen years, including construction, operation and rehabilitation. It is anticipated that the project would provide a major economic boost to the Central West, employing up to 1,289 direct and indirect jobs during construction, and 788 direct and indirect jobs during operation. The project is currently under assessment by the NSW Department of Planning, Industry and Environment. During his spare time, Tony helps run the 396 hectare family farm at Crookwell, and he enjoys spending time with his family which includes six grandchildren at home near Orange.
Dr. Hayes interviews Dr. Allen Lichter for a second time on ASCO. TRANSCRIPT SPEAKER: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. [MUSIC PLAYING] DANIEL F. HAYES: Welcome to JCO's Cancer Stories-- The Art of Oncology, brought to you by the ASCO Podcast Network, a collection of nine programs covering a range of educational and scientific content and offering enriching insights into the world of cancer care. You can find all of the shows, including this one, at a podcast.asco.org. Today, our guest is Dr. Allen Lichter, the former CEO of the American Society of Clinical Oncology. Dr. Lichter has previously been a guest on this program in regards to his role as a radiation oncologist back in the early days and the research he did. But today, I'm going to ask him more about the history of ASCO. To begin with, Dr. Lichter has leadership roles with Cellworks and Lifelike. He has a consulting or advisory role with Integra, Ascentage Pharma, L-Nutra, and TRG Healthcare. He's also received travel accommodations and expenses from Cellworks. Dr. Lichter, welcome to our program again. ALLEN LICHTER: Dan, it's great to be here. DANIEL F. HAYES: Terrific to have you. As I said, the last time we spoke, I really was focused on having you tell us about the evolution of radio psychology in this country, and was a terrific interview. I hope our listeners have had a chance to listen to it. But since you've had so much to do with ASCO, you've been a president of ASCO, you've been a CEO of ASCO, you're pretty much done it all, I thought we'd take an opportunity to pick your brain about the history of ASCO. So to start with, I think a lot of our listeners probably don't know much about how ASCO got started in the first place. You want to give us a little background about that? ALLEN LICHTER: I think to understand ASCO, you have to go back, really, to the very beginnings of medical oncology. In the 1940s and '50s, a few chemotherapy agents were invented and brought into practice. Toxicity was high. The benefits weren't that great. But there was some hope that through scientific discovery and research, things could get better. In 1954, the NCI created the first National Drug Discovery program, which began to catalyze the discovery of more chemotherapy agents. And it's into that environment that a group of, who were then internal medicine docs, started to use chemotherapy more and began creating some training programs in medical oncology. That led in the early '60s to an organizing meeting that took place at AACR. And there were 50 attendees. It was on November 4, 1964. So here were these physicians who were interested in cancer, who got together at the American Association of Cancer Research and formed an organization concerned with the management, the clinical management, of cancer. And you go back to that early meeting and read the following sentence, quote, "This society shall not be a society of chemotherapeuticsts only. The society should consider the total management of cancer." They established dues of $10 a year, and they agreed to meet again at the following spring. And on April 10, 1965, at the next AACR meeting-- or, actually, the original meeting was off cycle from AACR. And then, in '65, they met formally at AACR for the first time. That sentence, that this is not a society of chemotherapeuticsts, as they wrote it-- because there were no medical oncologists-- but was a society for cancer physicians of all persuasions, was a fundamental organizing principle of ASCO, a principle that holds true today. And it is one of the great strengths of ASCO, is that it welcomes and embraces and enjoys the membership of oncologists of all subspecialties. And then, as you move ahead in the development of medical oncology, you get to the American Board of Internal Medicine that had pressure from outside agitators, people like PJ Kennedy and Paul Calabrese and Paul Carbone, and Jim Holland and Tom Frei and Al Owens, to form and create a subspecialty board in this nascent specialty of medical oncology. And that came into fruition in the early 1970s. And if you go back into the '70s, ASCO had a revenue of $25,000. That was the annual revenue of the organization. It's now probably close to $150 million. And ASCO is number two in terms of the size of its revenue of all medical professional societies in the US behind only the American Medical Association. So that first idea of founding the society, creating it as a multidisciplinary society, and standing back and watching it grow as the specialties in oncology grew, has really borne fruit over many, many years. There were seven founders of the organization. Their names are in the ASCO office. People who come to the ASCO office can come into our big boardroom, which is called the Founder's Room, and see the bios of Fred Ansfield, Robert Talley, Harry Bissell, William Wilson, Herman Freckman, Edonis Goldsmith, and very specially, Jane Wright-- Dr. Wright being not the only female in this group at the time, one of the few African-American medical oncologists in the nation. She had a distinguished career and has had many awards and tributes given to her both by ASCO and by AACR. So the society moved along. And I like to say to people, you know, what is really startling is that the field of medical oncology, the medical oncologists forgot to establish the American Society of Medical Oncology. They are, to this day, the only medical subspecialty in internal medicine that does not have its own dedicated professional society. ASCO has filled that role from its inception through the time that the specialty boards were created. And to this day, there is no ESMO, there is only ASCO. And so ASCO has this dual organizational responsibility, one to the entire field of oncology, and then a very special relationship with the field of medical oncology, as we represent that specialty almost exclusively. DANIEL F. HAYES: Let me jump in. There, for example, is a Society of Surgical Oncology and the American Society of Therapeutic Radiation Oncology, which I believe you were president of as well. So I agree with you that the internal medicine part of it is really unique in terms of ASCO serving as a society for everybody, even though there are these other societies that represent the individual modalities. ALLEN LICHTER: Yes. There is nothing quite like it. It has worked well. We have never, to my knowledge, had an uprising of the medical oncology specialty saying we need a different organization. The community oncologists form the Community Oncology Alliance, COA, which is a thriving organization that pays a lot of attention to those special needs of community practice in oncology. But even then, virtually all the members of COA are members of ASCO as well. So as the society moved along and it grew beyond its $25,000 revenue, we hired a professional management firm to run the administration of the society, a firm called Bostrom. They were based out of Chicago. And for many years, a guy named Al Van Horn was the executive director of ASCO. He was an employee of Bostrom, but his salary was paid by ASCO. And the society grew, but we retained this relationship with ASCO until we got into the early 1990s. I was on the board at that time, but I'll digress for a moment to talk about how I got on the board. So at the annual meeting of ASCO, they always had a member's meeting. And it was like at 4 o'clock in the afternoon. And it was in one of the meeting rooms. And the dais was set with a long table. And the board of directors sat at the table. And the membership who, those that came, sat in the audience and heard from the leaders of the organization what was going on, et cetera, et cetera. And then, they had open mic that members could come forward and ask questions. So I arose from my seat and went to the microphone. And I said, gentlemen-- because they were all men-- you have extolled the multidisciplinary nature of this organization that existed from its founding up to the present day. But as I look at the assembled board in front of me, they are 100% medical oncologists. And you have radiation oncologists and surgical oncologists and pediatric oncologists and gynecologic oncologists and so forth in the organization. And we have no representation on the board. And they said, thank you, Dr. Lichter, for your question. And down I sat. But a little seed was planted, I guess. Because over the next couple years, the board decided to enlarge its membership and have dedicated seats for a radiation oncologist, a surgical oncologist, and a pediatric oncologist, seats that exist today. And I got a call, OK, big mouth. You raised this. You raised this. We're going to run you for the board. And I said OK. And I got elected to the board as the first radiation-- sitting in the first radiation oncology seat. I watched as the society grew. And we recognized, we needed to take over our own management, to move away from the hired hands at Bostrom and to have our own organization. And it was under the steady hand of then President John Glick, who led us through this transition. We interviewed candidates to be the then called the executive vice president and hired John Durant, who was then at the University of Alabama. And John took us through that transition. We opened an office in Alexandria, Virginia, and began to hire staff. And John was an absolutely sensational leader for the organization during that important transition. And that was in kind of the mid '90s. John Glick was one of the truly terrific presidents of ASCO. And I contributed to that because I ran against John. And John wanted an election. And it was my doing that John became president of ASCO. I graciously lost to him. They decided, for some reason or another, that they would run me again for president. And I did win that election. I ran against Charles Balch, who was a surgeon. And Charles later succeeded John Durant as the CEO of ASCO as ASCO's second CEO. I was president '98-'99 was my year. And the organization continued to grow. I rotated off the board and was happily in my job at Ann Arbor. And then, Dr. Balch was stepping down and they were looking for a CEO. And I threw my hat in the ring and became the CEO of the organization in 2006. And that's a big, broad overview of the organization. It now has 45,000 members, as I say, a wonderful and steady revenue stream, although it's been a challenge over the last 18 months with COVID and losing the physical annual meeting. But those are the broad brush strokes. DANIEL F. HAYES: So my impression, and correct me if I'm wrong, I mean, the original seven founders, I've read the minutes of the original meeting. And they were pretty interested in how do you dose reduce? How do you get this drug? How do you get that drug? And I think there was maybe one or two scientific presentations. But correct me if I'm wrong. By the time came on the board, ASCO was principally a place to present your data and publish your papers in JCO. By that time, personally, I feel that it began to roll back into saying, look, 60% to 70% of our members are community oncologists. And I've seen a huge increase in ASCO's focus on the community oncologist. Is that perception all true, or am I making it up? ALLEN LICHTER: I think that that's true. If you look back at the first annual meeting in 1965, I think there were three or four papers presented. They were all clinical, and in some respects, as they should be. Because people wanted to begin to share their experience with using these new highly toxic agents. There was just no precedent. Everything was done through trial and error and clinical research and experimentation. And so the results were shared. And the society continued along in that vein not so much as a pure scientific society, and certainly, not so much as presenting basic science research, but presenting clinical research. I think at the time, it was felt that the more pure science was AACR. And ASCO was going to present the clinical stuff. And as you know, for the first many, many years of the society, the two societies met back-to-back. So a typical meeting in the 1980s was Monday and Tuesday was AACR. Wednesday was an overlap day, and then Thursday and Friday was ASCO. And so that dichotomy of, there is the science, especially the bed science, and there's the clinical science at the end of the week, existed for quite some time until ASCO grew its meeting enough, worked out an arrangement with AACR, and the two meetings divided, with AACR meeting in April and ASCO meeting in June-- again, something that still exists to this day. DANIEL F. HAYES: When you were CEO, though, for example, you initiated the Department of Clinical Affairs or something to that effect. And also, how did the affiliates begin to grow up? I mean, it was all news to me when I became president. I knew nothing about that. ALLEN LICHTER: Over the years, not only did ASCO develop as a national organization, but within each state, either a medical oncology or an oncology writ large society was formed. And just about every state had them. It was not a revolutionary idea to begin to try to tie the affiliates into ASCO. Not that were floundering in any way, but they could use some support speakers to be arranged for their own annual gatherings. And we became much more interested in making sure there was a dialogue between ASCO central and what was going on in the trenches of physician practice in the community and around the states. And so we began to bring the state affiliates closer to the organization. A lot of this was done under the guidance of Joe Bailes, who was president of ASCO after me and had a prominent role in the government relations aspects of reimbursement aspects of the specialty. And Joe was very close to the state affiliates. That grew in importance and we ended up creating the state affiliate council and hearing from them at each board meeting and then finally, to the point where we had the president of the state affiliate council who was invited to attend every board meeting, and to be part of the board deliberations. So it's complex to knit the whole thing together. Medical oncology really, in essence, grew up as an academic discipline. It was started at major medical centers like Sloan Kettering and MD Anderson and so forth. You might be too young to remember, but patients used to be admitted to hospital to receive their chemotherapy. And they certainly were admitted, often admitted to hospital to receive their radiation to some extent, because insurance wouldn't pay for it if it was given-- and there was no such thing as outpatient cancer therapy. But as the specialty then began to move out of these large academic hospitals and into the community, that began this whole infrastructure of state affiliate societies and our relationship up and down. We are not just an organization of academics, although we've been led mostly by academic physicians throughout our history. The community oncologists have a very important role to play not only in ASCO, but in the delivery of cancer care in this country. DANIEL F. HAYES: Actually, I am old enough. I remember I told many fellows that when I was a fellow, we put people in the hospital. All we had was prochlorperazine, Compazine, which doesn't work at all. And we would give them barbiturates not because it kept them from throwing up, but it kept them from remembering how much they threw up so they would come back and get their next treatment. So it was pretty barbaric. Now, all outpatient, which is fantastic. Actually, you touched on this briefly, but how about the evolution of ASCO as an advocacy organization in politics, which has taken a major step lately? ALLEN LICHTER: Even while we were under the management of Bostrom, we did have a legislative government relations team in Washington. And the first couple of fulltime employees that ASCO had were hired in the government relations side. And a lot of this was really, again, we had to represent medical oncology in important areas of billing and reimbursements and Medicare coverage and Medicaid coverage, and so on, and so forth. And as I said earlier, there was no one else to do it. We were, by default, those specialty society that was going to represent medical oncology. So we had to do that. The surgeons had their own. The radiation oncologists had their own, and so on, and so forth. But ASCO did that relatively early on. And of course, as the complexity of Medicare and Medicaid and private insurance, and the cost of care and inpatients and outpatients, and who's going to pay for what, where, and so on, and so forth, we have become deeply enmeshed in that. Because, again, it's our responsibility to do so. And I think the society over the years has done an excellent job of representing this field. DANIEL F. HAYES: Even to the extent that recently, we've set up a separate business, I think it's called the Association of ASCO, or ASCO assoc-- I can't remember what it's called. ALLEN LICHTER: Yeah, I think it's the Association for Clinical Oncology. Anyway, it's named so that it can also be called ASCO. But when ASCO was founded-- and this makes us different from a lot of our sister societies-- we were founded as a 501(c)(3). That's the tax code, educational organization. And as a 501(c)(3) educational organization, we could not engage very much in what is known as lobbying. We could advocate for legislation. We could do some gentle advocation for legislation. We could interface with regulatory agencies. So we were unlimited in our ability to talk to the FDA or the CDC or the Centers for Medicare and Medicaid and that. But we couldn't do very much on the legislative side. And we thought for a long time about whether that needed to be remedied or not. In the end, it was decided it did need to be remedied. That is, we needed to have the ability to have a bigger footprint inside Capitol Hill in the legislative process. Virtually, all our sister societies had that. And many of them were founded as-- and I'm not a tax expert but-- a (c)(4) or (c)(6) organizations, which gave them that ability. And ASCO was a (c)(3). in the end, we formed a new (c)(6), which is this Association for Clinical Oncology, that allows us to have a more visible presence on the legislative side of the house and the ability to influence legislation on behalf of cancer patients and cancer physicians. DANIEL F. HAYES: Yeah, I think most of our membership, probably especially the academics, have always just thought, well, I don't have to worry about this. ASCO has my back. And what I have seen in the last 10 years is, first of all, an increasing presence of ASCO on Capitol Hill. Again, many of our listeners may not know this, but twice a year, there is a so-called day on the Hill. And even when I got elected, I think there were 40 of us that did this. I had never done it before. It was a lot of fun, where we go out and meet with the senators and representatives and their staff, and with specific issues that we think are important for our patients. We just did this virtually last week. And I think there were 130 of us or something. That's increased quite a bit. And those discussions are now being led by what is essentially a PAC, a political action committee, this association but with a lot more influence that has had in the past. And I know I sound like I'm on a soapbox, but I've become a true believer, maintaining what you and your predecessors continued to emphasize, which is that we are not a trade union. We are there to improve patient care. And that's what we do. The topics we choose to discuss are related to things we feel need to be legislated for the purpose of improving patient care. I'm actually very proud of this, which is why I'm discussing it. I've had nothing to do with it except show up. I'm proud to ASCO who's done this. ALLEN LICHTER: Yes. And with the political action committee, it does give us the chance to have a presence at certain events that before, we couldn't, we could not have a presence then. It allows us to have influence as we can support those legislators that are sympathetic to the work that we're trying to get accomplished, and so on, and so forth. We resisted it for so long, it was time and the appropriate thing to do. And I join you in being proud of the organization to have just done it. DANIEL F. HAYES: So that's an advertisement. If any of our listeners would like to become part of the day's on the Hill, if you go into the volunteer corps, you can sign up and ASCP staff will then teach you what you need to do and how you need to do it, and how you need to say it. You can be part of this, and it's actually a lot of fun to do. And this association has very real guardrails set up so that we continue to advocate and lobby, again, for what we think is best for our patients. And that's another reason I was very supportive of it when it came around. ALLEN LICHTER: Your mentioning of volunteers makes me want to comment. Many of our sister societies, when I was CEO, the organizations that got together a couple of times a year were saying how difficult it was to get members to participate in the work of the society. Everybody was so busy in their practice environment, or their academic environment, or whatever. ASCO has always had exactly the opposite problem. We have way more of our dedicated members who want to participate in the society than we have places for them to participate. So it's a wonderful problem to have. It has been that way for as long as I can remember, and continues that way today. It's a real tribute, I think, to the specialty as to how dedicated our members are in being willing to volunteer and serve, and really devoting a huge amount of time. You've been president. You've been on the board. That service is all volunteer and takes, over a career, hundreds and hundreds and hundreds of hours. But people do it actively and willingly. And our only problem is I wish we had more spots for people to have positions inside the organization. DANIEL F. HAYES: When I became president, I think I had 220 slots, or something like that, to fill. And I had something like 2,000 people volunteer. And I agree with you. Actually, was it under your watch that the designated seats for community oncologists for the board became a reality? Or was that before you? ALLEN LICHTER: That existed before. That was added. And I can't remember if it was added at the time the subspecialists were added or whether it came a separate thing. But yes, and it goes to what we were talking about before, which is with community oncologists, we felt very important even as today, that they needed a seat at the table for ASCO. So we have this dedicated seat for a community oncologist, and even have brought community people into the undesignated seats. We learn a lot from our community colleagues and need them and have them close at hand. DANIEL F. HAYES: I have said many, many times before I was on the board and when I was president that the academics, including myself, will speak up to show you how smart they are. But the community oncologists on the board were there for a very real reason. And I learned very quickly my first year on the board, keep my mouth shut and listen to these folks because they had a lot to tell us. They're there because they want to make things well. I think the academics are too. They want to make things better. But the community oncologists are giving money up out of their pocket. They could be seeing patients. And they're there on the board because they feel that they have a real set of concerns. And again, I'm proud of the fact that the board of directors is made up of a fair number of them who have really been instrumental in what we do and how we do it. ALLEN LICHTER: Yeah. I have to be a little bit of a Homer and say, that certainly, Dan, you're at the University of Michigan. And I used to be at the University of Michigan, but we've had three presidents of ASCO in modern times, my presidency and your presidency, and now Lori Pierce. And of course, two of those people are-- DANIEL F. HAYES: Actually, Doug Blayney, so four. ALLEN LICHTER: Doug was president while he was at Michigan. Absolutely, don't want to forget Dr. Blayney. And of course, two of those presidents were radiation oncologists from the department I used to lead. And we are very proud of the work that the Red Hawks from Michigan are doing inside ASCO. DANIEL F. HAYES: Go blue. I think that pretty much uses up our alotted time here. Is there anything else about the history of ASCO you think that our listeners ought to know about that they might not? ALLEN LICHTER: You know, we are regarded as really, a highly successful and highly effective society. Many organizations in medicine have come to look to ASCO for ideas, for policy positions, for ways of running the organization. We have a fabulous staff made up of both of about five physicians in our senior staff and a number of distinguished professionals who support our policy and membership in meetings, and so many other parts of our organization. We created the Journal of Clinical Oncology out of nothing and built it into the most important clinical journal in oncology today. It's an ever-changing critically important piece of the oncology ecosphere. And it's an organization I'm very proud of. DANIEL F. HAYES: Me too. So with that, I will say to you what I said to you last time, thanks for all you've done for the field. Thanks for all you've done for ASCO, and thanks for all you've done for me personally as well. And appreciate the time you spent with us today ALLEN LICHTER: Dan, it's been a pleasure. [MUSIC PLAYING] DANIEL F. HAYES: Until next time, thank you for listening to this JCO's Cancer Stories-- The Art of Oncology podcast. If you enjoyed what you heard today, don't forget to give us a rating or review on Apple Podcasts or wherever you listen. While you're there, be sure to subscribe so you never miss an episode. JCO's Cancer Stories: The Art of Oncology podcast is just one of ASCO's many podcasts. You can find all the shows at podcast.asco.org. [MUSIC PLAYING]
Team list Tuesday was in full-swing today. The boys unpacked all the news from all the teams. Guests included Elly Wicks, Denan Kemp, Reed Mahoney, Alex Wilkinson and of course Sean Ormerod from Sportsbet. Don't miss a new super star Lee from Blayney giving it to fletch. Plenty of laughs as always.
Roosters fan Lee from Blayney called up and she had a few current and former Roosters on her radar.
Leah Blayney (Head Coach - Australia Young Matildas (U20) and Future Matildas) joins as our special guest on the pod to discuss the Young Matildas, Future Matildas and Legacy '23.We ask Leah to share her thoughts on Legacy ‘23 and how it will help the Young Matildas qualify for major tournaments.Dale delves into Leah's link with the Macarthur Rams Football Club.Leah also shares how legendary football coach Tony DiCicco helped shape her as a coach and a person.We discuss qualifying matches for the AFC U20 Women’s Asian Cup 2022 and AFC U17 Women’s Asian Cup 2022 which will be held in Shepparton (Vic) and Cessnock, NSW respectivelyU20 R1 Quals 14-22 August (prev March) - Shepparton, VicU17 R1 Quals 18-26 September (April 2021) - Cessnock, NSWEric discusses Jets Academy players selected for U17 elite games.https://www.newcastlejetsfc.com.au/news/jets-academy-players-selected-elite-gamesCheryl wants some answers why we're not seeing more Matildas from VictoriaRead a great background article on Leah from Lucy Zelic - https://theworldgame.sbs.com.au/highly-ambitious-blayney-keen-to-climb-matildas-coaching-ranksHot topicsFootball Queensland - History websiteFemale Football WeekRound Results & LadderPlayer of the round?Goal of the round?Save of the Round?Pass of the round?Tackle of the Round?WSWvMCY 1-0 (Thursday)PERvSYD 2-6 (Thursday)NEWvADL 1-2 (Friday)MVCvCBR 1-1 (Sunday)
On this show, we talked about how financial planning integrates with portfolio management, why the next 10 years could give us low interest rates, and how to invest in such an environment with Jeff Porter, CFA, CFP and Chief Investment Officer at Sullivan Bruyette Speros and Blayney. Listen to learn why expecting double digit returns over the next 10 years could be unrealistic! You can learn more about Jeff at SBSBLLC.com and LinkedIn. We’re honored to have been named one of the top podcasts from investing! We’re on YouTube, check us out! George is honored to be included on Investopedia's list of the Top 100 Financial Advisors for 2019! Have George speak to your organization. You can learn more about the show at GeorgeGrombacher.com, Twitter, LinkedIn, Instagram and Facebook or contact George at Contact@GeorgeGrombacher.com.
In this Six-Gun Justice Conversation segment, Paul chats with Jerod Blayney, a dedicated collector of the Hartland TV Western horse and rider sets and gunfighter figurines, as well as being the administrator for the Hartland TV Western Figurines Facebook group...Support the show (https://www.paypal.com/donate/?token=suROpN0f2hQhThddyTchkgR4CytqmFW705g1jNJV3rCDT8OLxSCXKbf8j0oyifmCvb3fAW&fromUL=true&country.x=US&locale.x=en_US)
Today we're talking all about cause and effect, especially when it comes to talking to our children about money. The ideas we plant into our children's heads from a young age can change their relationship with money. We're also talking about Coronavirus and the effects it has had on the economy, ranging from businesses, economics, the stock market, all the way to retirement. Greg is a CPA and Co-CEO of Sullivan Bruyette Speros & Blayney. He enjoys making an impact on the firm in its continued growth and development as well as providing financial advice to high net worth and ultra-high net worth clients. He co-founded the firm in 1991 and has over 35 years of business, investment management, and financial planning experience. Find more about Greg here: https://sbsbllc.com/
What's the one landmark that the three neighbouring council areas of Blayney, Cabonne and Orange have in common? It's one item on the list for more co-operation projects as a new alliances gets under way.And, tree crews are launching their annual battle against an invasive beetle that's damaging Orange's Elm trees.
In episode 25 of the Business Leaders Breakfast Series, Sam is joined by Mayor of Blayney Shire Council, Scott Ferguson. A plumber by trade, Scott has served on Blayney Shire Council since 1999 and was elected Mayor in 2012. W: https://www.blayney.nsw.gov.au/
Hey Dude, I called to riff about recording my Uncle Woody's fantastic stories and to geek the enduring influence of the film My Dinner with Andre. PEOPLE: Bob Dylan, Howard Hughes, Blayney F. Matthews, Jack L. Warner, Al Matthews, Caryl Chessman, Barbara Graham, Gene Siskel, Roger Ebert, Ed Masry, Albert Finney, Erin Brockovich, Danny Wolf PLACES: Los Angeles, Venice, The Gas House, Angeles National Forest, Altadena THINGS: Theme Time Radio Hour, SiriusXM, Heaven's Door, Outlaw Country, 1920's, 30's, 40's, 50's, 60's, FBI, "My Dinner with Andre", U.S. Navy, "Erin Brockovich", Bobcat Fire SOUNDS: wind, footsteps, gravel path, Laguna Sawdust Cowbell Chimes, birds, train, muscle car, crow GENRE: storytelling, personal narrative, personal journal PHOTO: "Wallace and Andre" via Google shot on my "new" iPhone6 RECORDED: September 21, 2020 in the new "Keystone Garden Studio" under the flight path of the Bob Hope Airport in Burbank, California GEAR: Sony ICD PX370 digital voice recorder and Sony ECM CS3 "tie-clip" microphone. HYPE: "It's a beatnik kinda literary thing in a podcast cloak of darkness." Timothy Kimo Brien (cohost on Podwrecked and host of Create Art Podcast) DISCLAIMER/WARNING: Proudly presented rough, raw and ragged. Seasoned with salty language and ideas. Not for most people's taste. Please be advised.
Karen Wawrzaszek is the Principal at Sullivan, Bruyette, Speros & Blayney. She is an executive that consults with families and institutions on investment and financial planning programs. Over the past 20 years, she's led a variety of impact investment initiatives and consulted with families of wealth that are on a journey to align their values with their investment and philanthropic initiatives. Karen also works with not-for-profit organizations to better understand the alignment of their missions and their investment capital. In this episode… Asking a donor for money is hyper-competitive, and even more so now that donors don't just want to write a check. Now, they want to transform a problem and truly make an impact. But donors are having a hard time finding the right not-for-profit that will help them understand the motivating core values that, in turn, make giving more transformational. If you're looking to practice holistic philanthropy that actively involves donors beyond their checks and transcends to the next generation of wealth owners, Karen Wawrzaszek of Sullivan, Bruyette, Speros & Blayney is here to talk about holistic philanthropy and impact investing. In this episode of the Philanthropy212 Podcast, Penny Cowden and Karen Wawrzaszek of Sullivan, Bruyette, Speros & Blayney talk about techniques for helping donors come up with core values that inspire intentional giving, understanding why donors give, how to demonstrate the impact of gifts, and more.
Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2020.07.23.217695v1?rss=1 Authors: Blanden, A. R., Yu, X., Blayney, A. J., Demas, C., Ha, J.-H., Liu, Y., Withers, T., Carpizo, D. R., Loh, S. N. Abstract: Missense mutations in the DNA binding domain (DBD) of the p53 tumor suppressor contribute to approximately half of new cancer cases each year worldwide. A primary goal in cancer therapy is to develop drugs that rescue the transcription function of mutant p53. Here we present a thermodynamic model that quantifies and links the major pathways by which mutations inactivate p53. The model is constructed by measuring folding free energies, zinc dissociation constants, and DNA dissociation constants of 20 of the most common DBD mutations in the p53 database. We report here that DBD possesses two unusual properties----one of the highest zinc binding affinities of any eukaryotic protein and extreme instability in the absence of zinc--which are predicted to cause p53 to be poised on the edge of folding/unfolding in the cell, with a major determinant being the concentration of available zinc. Eighty percent of the mutations examined impair either thermodynamic stability, zinc binding affinity, or both. Using a combination of biophysical experiments, cell based assays, and murine cancer models, we demonstrate for the first time that a synthetic zinc metallochaperone not only rescues mutants with decreased zinc affinities, but also mutants that destabilize DBD without impairing zinc binding. The latter is a broad class of p53 mutants of which only one member (Y220C) has been successfully targeted by small molecules. The results suggest that zinc metallochaperones have the capability to treat 120,500 patients per year in the U.S. SUMMARYRestoring tumor suppressing function to mutant p53 has the capability of treating millions of new cancer patients worldwide each year. An important step toward this goal is to categorize the spectrum of mutations based on how they inactivate p53. This study finds that the majority of the most common tumorigenic mutations compromise p53s thermodynamic stability or its interaction with zinc, and demonstrates for the first time that members of both classes can be reactivated in cells by synthetic zinc metallochaperones. These results serve to stratify patients for potential zinc metallochaperone therapy. Copy rights belong to original authors. Visit the link for more info
R A Blayney is the author of Transformation: Life Before Birth, Cosmic Consciousness and Alternate Realities. Mr. Blayney describes what it's like to question our perception of reality, with a taste of science and spiritual philosophy. His website is www.rablayney.com
R A Blayney is the author of Transformation: Life Before Birth, Cosmic Consciousness and Alternate Realities. Mr. Blayney describes what it's like to question our perception of reality, with a taste of science and spiritual philosophy. His website is www.rablayney.com
Chatting to Stefan White about his career was something I always wanted to do and when it came about, I was absolutely delighted to learn and listen to my favourite Louth footballer ever. In the first of this two parter, we talk about Stefan’s hero’s, how practice made perfect, O’Connells and his formative football years in ‘Blayney. You’ll notice Stefan’s Father, Stephen White, features strongly throughout both podcasts and why wouldn’t he? a Louth legend and indeed All-Ireland winner and most importantly a hugely influential figure in shaping Stefan’s career. Really excited to share this chat with you, I hope you enjoy it and tune in again for next week too. Stefan is next up in the Bord Gáis Energy GAA Legends Virtual Tour series this Wednesday check it out here: https://crokepark.ie/celebrating-legends-of-the-game SUBSCRIBE https://podcasts.apple.com/us/podcast/the-louthandproud-podcast/id1332511790 https://podcasters.spotify.com/podcast/3QAoNJCpdITOSkIb4IurgT/audience https://www.youtube.com/channel/UCTHIx2hVGem-8P_YzqZS95w/
The COVID-19 pandemic is a 'once in a century' type of event for aviation, but even this crisis won't change people's innate desire to travel says Patrick Blaney, Chair of UCD Smurfit School's Aircraft Leasing & Finance Programme.
My guest today is Jim Bruyette, CPA, CFP, Principal , CEO at Sullivan, Bruyette, Speros & Blayney, LLC with over $4.3 billion in assets under management. Jim started with $0 in assets under management and currently manages $4.3 billion! The timeless lessons you will learn from Jim are priceless. I hope you enjoy the show... --- Support this podcast: https://anchor.fm/smartmoneycircle/support
Episode 2 of the FFN ‘Mentor of the Month’ see’s FFN director Tom Rookyard joined by James Millner of Rosedale Charolais stud at Blayney, NSW. James is the principal of Rosedale Charolais one of Australia’s biggest polled Charolais studs, selling more than 150 bulls a year. James’s business also has a commercial enterprise and also recently involved in a paddock-to-plate brand (Rosedale Ruby) which is feeding the growing Asian appetite for quality beef. James won the 2017 Farm Weekly Beef Farmer of the Year award; in 2018 the Rosedale Ruby striploins won the 2018 World Steak Challenge, beating over 200 entries. Listen to chat about James career journey and learnings.
“When should I start planning for retirement?” On this episode of “The Deal – Unscripted” we're talking to Dan Graff of Sullivan Bruyette Speros and Blayney about what is involved in developing a retirement plan for entrepreneurs and when they should start planning to exit their business. You won’t want to miss this one!
“When should I start planning for retirement?” On this episode of “The Deal – Unscripted” we're talking to Dan Graff of Sullivan Bruyette Speros and Blayney about what is involved in developing a retirement plan for entrepreneurs and when they should start planning to exit their business. You won’t want to miss this one!
“When should I start planning for retirement?” On this episode of “The Deal – Unscripted” we're talking to Dan Graff of Sullivan Bruyette Speros and Blayney about what is involved in developing a retirement plan for entrepreneurs and when they should start planning to exit their business. You won’t want to miss this one!
15 października 1582 - wprowadzono kalendarz gregoriański.15 października 1810 - Polacy odparli atak Brytyjczyków pod Fuengirolą.15 października 1894 - afera Dreyfusa we Francji.15 października 1917 - rozstrzelanie Maty Hari.15 października 1941 - kara śmierci dla Polaków udzielających schronienia Żydom.15 października 1944 - operacja Mickey Mouse.
Former NI & Linfield goalkeeper Alan Blayney discusses the highs and lows of football, from title wins and teammates to battling self-doubt and overcoming a serious illness.
Martine Lellis has had a unique career with Sullivan Bruyette Speros & Blayney (SBSB). She started out as an associate advisor, and after seeing the firm sold to a bank, she later moved into a mid-level management role and continued climbing all the way up to become the firm’s Chief Operating Officer and Principal. She then joined four other principals to buy the firm back from the bank, making it private again. In this episode, Martine shares the process of selling and buying back the firm and how her role has changed throughout the years with SBSB. We also discuss the company’s model for serving affluent clients and why they offer tax preparation services on top of financial planning and investment management. Listen in to find out the challenges that surprised Martine the most and her biggest breakthrough in her career. For show notes and more visit: https://www.kitces.com/126
Emily Purdon started her career in 2016. She quickly realized that her CFP® certification and financial planning degree through Virginia Tech hadn’t really prepared her for the realities of being a planner - and she felt that the comprehensive planning she learned at her role with SBSB (Sullivan Bruyette Speros & Blayney) was both exciting and beneficial to clients in a way she hadn’t imagine was possible.
Greg Sullivan is president and CEO of Sullivan, Bruyette, Speros & Blayney, a wealth management firm providing financial planning and investment advice to high-net-worth and ultra-high-net-worth clients. He has over 35 years of business, investment management, and financial planning experience. SBSB currently services approximately 1000 clients and manages over $3.7 billion in assets. “Never stop learning, never stop reading and never stop improving. It's too easy to get caught up in the activity of a business and just focusing on the day-to-day activities and the hiring of people and changing your business that we stop the learning process. And I mean learning in new areas not just in your skill set. But the reading of books that are outside of your normal skill area. Reading about leadership or great events that have happened in the world. You know those things just open your eyes to different ways to think about your business and communicate what you are doing”…[Listen for More] Click Here for Show Notes To Listen or to Get the Show Notes go to https://wp.me/p6Tf4b-6EF
On this show, we talked about the potentially devastating effect emotions can have on someone’s financial situation and how to avoid it with Greg Sullivan, CFP, CPA, author and Co-Founder of Sullivan, Bruyette, Speros and Blayney. Listen to find out how Greg thinks you can have the tough conversations with family that need to be had! For the Difference Making Tip, scan ahead to 18:49. You can learn more about Greg at RetirementFail.com, SBSBLLC.com and LinkedIn. To find Retirement Fail, click here. Please subscribe to the show however you’re listening, leave a review and share it with someone who appreciates good ideas. You can learn more about the show at GeorgeGrombacher.com, or contact George by clicking here.
Strive to Learn and Educate Yourself What is Right and What is Wrong Time Stamps and Contact Details for this Episode are available on www.HorseChats.com/MeganJeorgLC Music - BenSound.com Interviewed by Glenys Cox
Another programme with Pete Blayney Hypnotherapist
Strive to Learn and Educate Yourself What s Right and What is Wrong Time Stamps and Contact Details for this Episode are available on www.HorseChats.com/MeganJoerg Music - BenSound.com
Interview with Douglas W. Blayney, MD, author of Critical Lessons From High-Value Oncology Practices
This week we chat with CQUni Dean Professor Bill Blayney. We hear how as a child he was groomed as a singer, but also was a champion athlete. Bill tells us how he was inspired by his sister to cook and had dreams of being a successful chef. We learn how he broke new ground by becoming Australia's first ever male home economics teacher and became a role model for male students wanting to become chefs. We hear about his time working for TAFE before moving to CQUni and we learn about the pressures of being Dean of a busy university school. We also discuss his wishlist for the future of the Uni and find out how he winds down after a busy day.
"I think if you're starting out or wanting to start out, this episode will give you the motivation you’re looking for." EPISODE 4 Hello to you, This is Chris Godfrey again, I’m here to introduce our next guest on the podcast. Her name is Margaret Paton, and she is a professional writer out of Blayney , NSW. What’s great about Margaret and this episode… is that Margaret Paton is probably in the exact spot that everyone wants to be… she's escaping the rat race and now working for herself full time. I think if you're starting out or wanting to start out, this episode will give you the motivation you’re looking for. Margaret Talks about something she calls her “pitch deck”, and why it’s a been a big part of achieving that monthly financial milestone of generating $10,000 in one month for the first time since she has gone 100% solo, at least I think it’s the first time… sorry Margaret if i’ve got that wrong. But nevertheless.. If you’re looking to get that $10,000 a month milestone and become your own boss... even if you’re not a writer, the Pitch Deck is something that will help you get towards that goal. Note: Yes.. I know a “Pitch Deck” is also used to name a Sales Presentation :) Enjoy! SHOW NOTES To get a free copy of the book mentioned on the podcast, just go to http://quickmarketingtrick.com.au/freebook To get in contact with Margaret Paton, go to: http://realcommunications.com.au/
Contact Us www.realfoodchain.wordpress.com/contact-us/ Hello and welcome to episode two of the Real Food Chain podcast! I’m Jon and we’ll hear from my co-host Rich later in the show. This month’s focus is urban farming here in sunny Australia. Rich will be talking with Margaret Paton about her experiences growing food in her Blayney backyard using permaculture principles. Before that let’s have a deeper look at urban farming. This system of food production has much to recommend it. Food miles are reduced to zero. This strips all the green house gasses out of transport. If you also urban farm organically, and I’ll assume we’re all on that page, then you’re building soil carbon. Pulling CO2 out of the atmosphere and holding it in the soil, where it belongs. You are also not adding to the demand for poisons to be sprayed on your food. Basically a win, win, win situation! In the upcoming interview Margaret talks about an extremely small garden which was her inspiration. This is worth bearing in mind. The amount of food we can grow in a small space is quite astonishing. Most of us have seen commercial market gardens and they are spread out affairs. Looking more closely we see this is not for the benefit of the plants but to allow tractor access for spraying of artificial fertilisers, herbicides and pesticides. If we grow in spaces better suited to humans and plants we can stack the plants quite closely. This has the advantage of shading out weeds, reducing water loss through evaporation and wildly increasing productivity. Another benefit from small scale urban farming is the harvesting method. Instead of removing the whole lettuce to ship it off to a market, we can pick the outer leaves as we need them, allowing the lettuce to continue to grow. This maintains ground cover and means we don’t need to eat a whole lettuce before it goes off. You will notice flavour changes over the growing season but these are not off putting. I’ve done this and four lettuce, some silverbeet and a patch of rocket I trimmed in sections weekly kept four people in salad greens for seven months. There is, as I’ve said much to recommend urban farming. Much to recommend permaculture too but I’ll let Margaret tell her take on that philosophy. So here is Margaret Paton with co-host Rich. Margaret's Interview here. I hope that’s got you thinking. 10% of your food sounds like a good first target to aim for. We’d love to hear your thoughts on this. You reach us through the contact page on the website at www.realfoodchain.wordpress.com/contact-us/ which is also in the show notes. Equally if you think you’d make a great guest or know someone else who would contact us at the same page. We’d love to hear from you. Next month we plan to look at gut health and what we can make and do for ourselves to support this part of our health. Until then, goodbye.
After a freezing afternoon in Blayney, we were joined by Killian Clarke, Padraig Faulkner, Mattie McGleenan, Finbar O'Reilly and Paul Fitzpatrick to discuss today's draw with Monaghan. If you enjoy it, please share on social media - we'd appreciate it!
Eleanor Blayney, CFP is the Consumer Advocate for the Certified Financial Planner (CFP) Board of Standards, reaching out to consumers to help them understand how financial planning and CFP professionals can improve their lives. A recognized conference speaker and author of the book Women's Worth, she has played a pioneering role in shaping the financial planning profession. Blayney has taught for the College of Financial Planning and helped develop practice standards and ethical requirements for CFP professionals in the U.S. The greater part of her career was spent as Managing Director of SBSB, where Blayney helped build one of the largest independent wealth management firms in the country. For twenty-plus years, she worked with individual clients to help them articulate and plan for their financial goals. As the only woman in the firm, she drew upon her intuition, communication strengths and facility for sustaining relationships to serve hundreds of clients in the Washington, DC metro area and around the country. Passionate about finding ways to foster gender parity in the financial planning profession, Blayney helped spearhead the CFP Board's Women's Initiative (WIN) to address the industry's “feminine famine.” On this episode of the podcast, Blayney speaks to gender disparity in the industry and discusses the CFP Board's work to reach out to young women and attract a more diverse workforce. Key Interview Takeaways The two root causes of gender disparity in the financial industry are lack of knowledge and discriminatory firm culture. “You can't be what you can't see,” and until young women are made aware of opportunities and introduced to role models in the financial industry, Blayney argues that firms will have difficulty appealing to talented women. Combat lack of awareness with advocacy partnerships that give industry representatives the chance to tell their stories. Through the ‘Faces and Voices of Diverse CFP Professionals' campaign, the board is working with organizations like Invest in Girls and Rock the Street Wall Street to connect speakers with their target audience and give young women a sense of what the profession looks like. The financial planning industry is a good fit for women because it offers a sense of purpose and meaning. Blayney contends that the profession allows for the opportunity to create meaningful relationships and provides a creative outlet that appealed to her as a young professional. Educational opportunities in the industry must be both relevant and accessible. The CFP Board has approved 300-plus registered programs around the country, both traditional classroom and online. Candidates for certification with a professional contact are far more successful. The CFP Board WIN-to-WIN mentor program provides the opportunity to connect prospective female professionals with advice and support. Investing in a diverse workforce improves outcomes in terms of profit, productivity and morale. Blayney emphasizes the necessity of inclusiveness in the financial planning industry to build a sustainable workforce that truly represents those they serve. Connect with Eleanor Blayney Email: eblayney@cfpboard.org. twitter.com/EleanorBlayney CFP Board Website: cfp.net Resources www.investgirls.org rockthestreetwallstreet.com fortefoundation.org irelaunch.com Women's Worth: Finding Your Financial Confidence by Eleanor Blayney: http://amz... Learn more about your ad choices. Visit megaphone.fm/adchoices
Look Out (Luke 5:1-7) | Jude Blayney - Sunday 22nd Jan 2017
Summertime is not complete unless there is a soothing soundtrack to accompany the warm nights and long road trips. For the 32nd FIBER podcast we have asked Al Blayney to provide us with a mix to go with the flush of summer. As he just returned from a three week honeymoon, you can expect a … Read More
Today's guest and mediator-of-the-inevitable-craziness is Kay Blayney. Kay is a host on Cambridge 105, as well as working in various arts-related and education positions. We discuss our ideal celebrity, built from other celebrities' body parts; what laws we would enact should we suddenly rise to power; and whether or not you yawn in your sleep. ============================== Our plan is that this show will always be available for free, but super fans are encouraged to support The Conversation Hat via Patreon. You will get early access to new episodes and a special, patron-only episode once a month: www.patreon.com/conversationhat Super Loot want to deliver a box of nerd merch and geek chic to your doorstep each month, and will do so for a hilariously affordable price: www.superloot.co.uk/?ref=988 Sign-up to our mailing list: eepurl.com/bNX8A1 Remember to subscribe on whatever podcast app you're using now so you see new episodes when they go live. ============================== The Conversation Hat is hosted by Ben Pierson and Liam Taylor, and edited by Laura Elmer. Logo by Cheyenne Betts. Additional artwork by by Rebecca Timmons. Music by Liam Taylor The Conversation Hat is managed by Odd Creative Ltd.
Back after a hiatus, Neil van der Ploeg, Tim Guy and Jamie Finch-Penninger talk what's been happening in Aussie cycling, at home and abroad. Including discussion of Hayman's Roubaix win, Mt Baw Baw classic, Blayney to Bathurst, Asian Racing and more!
Writer Mark Blayney talks to us about his writing process, favourite forms and how to form a collection. As well as plenty of tips for budding young writers. markblayney.com
Jude Blayney - 21st September 2014
Have you initiated a plan to ensure financial health for you and your family? Listen to this weeks show as we discuss having a comprehensive financial plan with Jim Bruyette of Sullivan, Bruyette, Speros & Blayney located in Northern Virginia. Join you radio host Jim Kelley of RE/RMAX, Darius Jenkins of McLean Mortgage Co. and David Burger of DB Title and The Burger Law Firm each Saturday from 2:00 - 3:00 pm & Sunday form 11:00 a.m. - noon on 1260WRC AM radio as they discuss the latest in real estate.
Have you initiated a plan to ensure financial health for you and your family? Listen to this weeks show as we discuss having a comprehensive financial plan with Jim Bruyette of Sullivan, Bruyette, Speros & Blayney located in Northern Virginia. Join you radio host Jim Kelley of RE/RMAX, Darius Jenkins of McLean Mortgage Co. and David Burger of DB Title LLC each Saturday from 2:00 - 3:00 pm & Sunday form 11:00 a.m. - noon on 1260 WRC AM radio as they discuss the latest in real estate.
Label co-owner & DIP Resident Al Blayney puts together the latest FVF Podcast. He has gone for a straight up Techno Mix this time. Al plays everything from Dub Techno to Deep House. As usual with all his sets this is a Vinyl Only Mix apart from Tim Xaviers remix of Look Sharp FVF021 which is mixed on timecode vinyl using Tractor Scratch. Enjoy!
Long time FVF resident Al Blayney is well known for his warm up sets at the FVF Label nights in Dublin. He has previously played alongside Siphon, Sjaakflut and Miss Fitz and will be playing the upcoming New Year's Eve Party in the Twisted Pepper where FVF host together with Pogo and Electric City. This podcast takes the tempo down a notch with some very fresh house and techno. Enjoy.
© 2020-2025 Ivy Podcast Discovery LLC
